Literature DB >> 6187316

Hybridoma antibodies to poliovirus N and H antigen.

P Brioen, R J Sijens, R Vrijsen, B Rombaut, A A Thomas, A Jackers, A Boeyé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6187316     DOI： 10.1007/bf01314165

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  9 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  The modification of poliovirus antigens by heat and ultraviolet light.

Authors:  G L LE BOUVIER
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Stepwise degradation of poliovirus and top component by concentrated urea.

Authors:  D V Berghe; A Boeyé
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  The preparation of specific immune sera against type 3 poliovirus D-antigen and C-antigen and the demonstration of two C-antigenic components in vaccine strain populations.

Authors:  P D Minor; G C Schild; J M Wood; C N Dandawate
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

6.  Identification of poliovirus precursor proteins by immunoprecipitation.

Authors:  R Vrijsen; P Brioen; A Boeye
Journal:  Virology       Date:  1980-12       Impact factor: 3.616

7.  Evidence for a cloned hybridoma (HO-13-4-9) producing 2 kinds of antibody molecules different in specificity, one directed to Thy 1.2 gene products and the other to antigen on a subpopulation of Thy 1.1 thymocytes.

Authors:  E Kubota; H Ishikawa; K Saito
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  Highly sensitive enzyme immunoassay of rabbit (anti-human IgG) IgG using human IgG-beta-D-galactosidase conjugate.

Authors:  E Ishikawa; S Yoshitake; Y Endo; S Ohtaki
Journal:  FEBS Lett       Date:  1980-03-10       Impact factor: 4.124

9.  Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins.

Authors:  G Kronvall; H M Grey; R C Williams
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422
  9 in total
  15 in total

1.  Detection of coxsackie B virus infection using a rapid screening method.

Authors:  S A Bopegamage; A Petrovicová; M Stará
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  A monoclonal antibody that neutralizes poliovirus by cross-linking virions.

Authors:  A A Thomas; P Brioen; A Boeyé
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

4.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Monoclonal antibodies that disrupt poliovirus only at fever temperatures.

Authors:  I Delaet; A Boeyé
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Epitope evolution in poliovirus maturation.

Authors:  B Rombaut; R Vrijsen; A Boeyé
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies.

Authors:  R Vrijsen; B Rombaut; A Boeye
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  A liquid phase affinity capture assay using magnetic beads to study protein-protein interaction: the poliovirus-nanobody example.

Authors:  Lise Schotte; Bart Rombaut; Bert Thys
Journal:  J Vis Exp       Date:  2012-05-29       Impact factor: 1.355

9.  Poliovirus neutralization and the percentage law. Brief report.

Authors:  P Brioen; A Boeyé
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.

Authors:  B Rombaut; B Verheyden; K Andries; A Boeyé
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.